ARCHIVES

Emory Stops Patient Accrual After Discovering Problems In Management

This article is from The Cancer Letter archive.

Vol. 35 No. 25 | June 26, 2009

Download PDF Visit The Full Archive

Related Articles

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

Review Of NCI Intramural Program Offers Over 60 Recommendations For Change

July 7, 1995

Novel Treatment Modalities Tested Against Bladder Cancer

May 27, 2005

I-ELCAP Results Internally Inconsistent, Peter Bach Writes

June 24, 2011

Norton Succeeds Einhorn As ASCO President, Colorado’s Paul Bunn Is President-Elect.

May 11, 2001

NCI Plans to Fund FY 1985 R01s, P01s with Cuts 2.9-3.8% Under Recommended Groups, Centers Reduced 7-10%

March 16, 1984